154 related articles for article (PubMed ID: 11501779)
21. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
23. [Study of apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes in patients with epithelial ovarian cancer and their relationship with CA125].
Ma YX; Ye F; Chen HZ; Lü WG; Xie X
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):734-9. PubMed ID: 17565840
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
[TBL] [Abstract][Full Text] [Related]
25. Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors.
Ala-Fossi SL; Mäenpää J; Bläuer M; Tuohimaa P; Punnonen R
Eur J Endocrinol; 2000 Apr; 142(4):334-9. PubMed ID: 10754473
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary].
Kizawa I; Kikuchi Y; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):251-8. PubMed ID: 6833810
[TBL] [Abstract][Full Text] [Related]
27. The value of serum bcl-2 levels in advanced epithelial ovarian cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2006; 23(2):213-7. PubMed ID: 16720921
[TBL] [Abstract][Full Text] [Related]
28. Serum lactic dehydrogenase and primary carcinoma of the ovary.
Younis JS; Zeevi D; Hadani PE; Anteby SO
Gynecol Obstet Invest; 1989; 28(1):47-50. PubMed ID: 2777134
[TBL] [Abstract][Full Text] [Related]
29. Enzyme cytochemistry of benign and malignant cells in pleural and peritoneal fluid.
Blonk DI; Schaberg A; Willighagen RG
Acta Cytol; 1967; 11(6):460-5. PubMed ID: 4169938
[No Abstract] [Full Text] [Related]
30. Serum lactic dehydrogenase and its isoenzymes in patients with ovarian dysgerminoma.
Yoshimura T; Takemori K; Okazaki T; Suzuki A
Int J Gynaecol Obstet; 1988 Dec; 27(3):459-65. PubMed ID: 2904916
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
Dewan R; Dewan A; Jindal M; Bhardawaj M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma.
Ozgüroglu M; Turna H; Demir G; Döventas A; Demirelli F; Mandel NM; Büyükünal E; Serdengeçti S; Berkarda B
Am J Clin Oncol; 1999 Dec; 22(6):615-8. PubMed ID: 10597748
[TBL] [Abstract][Full Text] [Related]
34. Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma.
Fujii S; Konishi I; Suzuki A; Okamura H; Okazaki T; Mori T
Gynecol Oncol; 1985 Sep; 22(1):65-72. PubMed ID: 4018662
[TBL] [Abstract][Full Text] [Related]
35. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB
Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066
[TBL] [Abstract][Full Text] [Related]
37. [Role of Ca-125 in the differential diagnosis of adnexal mass in breast cancer patients].
Grabiec M; Nowicki P; Walentowicz M; Greźlikowska U; Mierzwa T; Chmielewska W
Ginekol Pol; 2005 May; 76(5):371-6. PubMed ID: 16145856
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
39. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C
Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505
[TBL] [Abstract][Full Text] [Related]
40. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
Tang BJ; Li L; Xu J
Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
